These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 496871

  • 1. Clinical effect of high doses of o-betahydroxyethyl-rutosides in patients with occlusive arterial disease.
    Bielawiec M, Lukjan H, Kiersnowska-Rogowska B, Dabrowski S.
    Bibl Anat; 1979; (18):378-81. PubMed ID: 496871
    [No Abstract] [Full Text] [Related]

  • 2. Clinical effect of O-betahydroxyethyl-rutosides (HR) in patients with occlusive arterial disease.
    Bielawiec M, Lukjan H, Grabowski R, Myśliwiec M, Korfel B.
    Bibl Anat; 1977; (16 Pt 2):152-4. PubMed ID: 603503
    [No Abstract] [Full Text] [Related]

  • 3. The effect of O-betahydroxyethyl-rutosides (HR) on the number of platelet-leukocyte aggregates in patients with occlusive arterial disease.
    Bielawiec M, Kiersnowska-Rogowska B, Dabrowski S, Lukjan H.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):103-8. PubMed ID: 88383
    [Abstract] [Full Text] [Related]

  • 4. [Effect of large doses of a flavonoid O-(betahydroxyethyl)-rutoside on some aspects of venous circulation].
    Forconi S, Guerrini M.
    Clin Ter; 1977 Feb 15; 80(3):229-55. PubMed ID: 852233
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of troxerutin on platelet aggregation in patients with arteriosclerosis].
    Myśliwiec M, Bodzenta A.
    Pol Tyg Lek; 1983 Oct 31; 38(44):1367-8. PubMed ID: 6674961
    [No Abstract] [Full Text] [Related]

  • 6. A double blind trial of oral O. B-hydroxyethyl rutosides for stasis leg ulcers.
    Mann RJ.
    Br J Clin Pract; 1981 Feb 31; 35(2):79-81. PubMed ID: 7020736
    [No Abstract] [Full Text] [Related]

  • 7. [Dosage of O-beta hydroxyethylrutoside in chronic venous insufficiency].
    Stemmer R, Furderer CR.
    Phlebologie; 1986 Feb 31; 39(4):995-1003. PubMed ID: 3562569
    [Abstract] [Full Text] [Related]

  • 8. The effect of hydroxyethylrutoside and its combination with acetylsalicylic acid in patients with obliterative atherosclerosis.
    Roztocil K, Oliva I, Prerovský I, Linhart J.
    Cor Vasa; 1989 Feb 31; 31(2):128-33. PubMed ID: 2663343
    [Abstract] [Full Text] [Related]

  • 9. [Efficacy of O-(beta-hydroxyethyl)-rutosides in the treatment of venous leg ulcers].
    Stegmann W, Hubner K, Deichmann B, Muller B.
    Phlebologie; 1987 Feb 31; 40(1):149-56. PubMed ID: 3554278
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of HR (O-Beta-Hydroxyethylo-Rutoside, Venoruton) on the deformability of erythrocytes in patients with arteriosclerosis obliterans of lower limbs.
    Lukjan H, Rość D, Chyzy R, Bodzenta A, Szpak A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985 Feb 31; 112(1):191-6. PubMed ID: 2581865
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of acute symptoms of hemorrhoid disease with high-dose oral O-(beta-hydroxyethyl)-rutosides].
    Annoni F, Boccasanta P, Chiurazzi D, Mozzi E, Oberhauser V.
    Minerva Med; 1986 Sep 29; 77(37):1663-8. PubMed ID: 3531924
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Results of a clinical trial with a new gel--association of a flavonoid and a heparinoid--in sports injuries.
    Lisý Z, Vrbicky B.
    Schweiz Z Sportmed; 1988 Jun 29; 36(2):91-3. PubMed ID: 2456611
    [No Abstract] [Full Text] [Related]

  • 18. [Platelet aggregation in atherosclerotic disease after administration of lysine acetylsalicylate].
    Evangelisti GB, Faggioli F, Garagnani A, Lama G.
    Minerva Cardioangiol; 1978 Jun 29; 26(6):447-60. PubMed ID: 673198
    [No Abstract] [Full Text] [Related]

  • 19. [Changes in morning platelet aggregation in patients with peripheral obliterating arteriopathy after evening administration of picotamide].
    Craveri A, Colombo L, Cristina M, Coloru M, De Angeli B, Lanfredini M.
    Clin Ter; 1991 Jan 15; 136(1):23-9. PubMed ID: 1826869
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.